Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | SIGLEC7 | Q9Y286 | 4/20 | 0.37 |
| ▸ | CD22 | P20273 | 8/20 | 0.36 |
| ▸ | SELL | P14151 | 1/20 | 0.36 |
| ▸ | SELP | P16109 | 1/20 | 0.36 |
| ▸ | MAG | P20916 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12341462 | 0.88 | NANP (0.47) | NANPSIGLEC7CD22SELLSELP | |
| SCHEMBL12341443 | 0.84 | NANP (0.44) | NANPCD22MAG | |
| SCHEMBL14454528 | 0.84 | NANP (0.44) | NANPCD22MAG | |
| SCHEMBL12730475 | 0.84 | NANP (0.44) | NANPCD22MAG | |
| SCHEMBL13839153 | 0.83 | NANP (0.49) | NANPL3MBTL1SIGLEC7CD22SELL | |
| SCHEMBL29226087 | 0.81 | NANP (0.60) | NANPL3MBTL1SIGLEC7CD22SELL | |
| SCHEMBL13402335 | 0.81 | NANP (0.43) | NANPSIGLEC7CD22SELLSELP | |
| SCHEMBL14175641 | 0.79 | NANP (0.40) | NANPCD22 | |
| SCHEMBL13477004 | 0.79 | NANP (0.40) | NANPCD22 | |
| SCHEMBL12341459 | 0.78 | NANP (0.39) | NANPCD22MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080319183-A1 | Branched Polymeric Sugars and Nucleotides Thereof | NEOSE TECHNOLOGIES, INC. (US) | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080319183-A1 | Branched Polymeric Sugars and Nucleotides Thereof | GALE, NUDT14, GNE | NANP 256/4885L3MBTL1 2824/4885SIGLEC7 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.